AAIC Advancements: IC-KDA 2027

The Alzheimer’s Association and the Korean Dementia Association are co-hosting AAIC® Advancements IC-KDA 2027: Translating New Treatments Into Real World Care on 16 and 17 April 2027 at the Conrad Seoul in South Korea, with the option to join online.

The last few years have brought new therapies, new diagnostic tools and stronger evidence on risk reduction, but getting them to patients is a different challenge, and one that looks very different from one country’s health system to the next. This two-day meeting brings together leaders in dementia research, clinical care and industry from around the world to work out how these advances can be put into practice across diverse health care systems, agree on best practice, and speed up the journey from clinical breakthrough to patient benefit.

Themes

• Risk-reduction and brain health strategies, building on studies such as US POINTER
• Emerging therapeutics, including the anti-amyloid treatments now reaching clinics
• Diagnostic innovations
• Care pathways and models of care
• Implementing these advances in different health care systems and closing the gap between research and practice

Scientific programme committee

The programme is being shaped by co-chairs So Young Moon and Gil Rabinovici, with Seong Soo An, Sheena Aurora, Yogi Shah, Hanna Cho, Geon Ha Kim, Jaeho Kim, Michael Rafii and Amanda Smith.

Abstracts and registration

Abstract submission and conference registration both open in December 2026. Speakers, fees and deadlines have not been announced yet. In the meantime, you can sign up for updates on the conference website.

The meeting is a good chance to network with scientists, clinicians and dementia professionals through ISTAART, the Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment. Membership is free for students and for people in low- and middle-income countries.

For general questions, contact AAICAdvancements@alz.org.

Click Here